JAZZ
Jazz Pharmaceuticals, Inc.Data: 2026-10-01
Quick Stats
Oct 01, 202660.5
AI Score
HOLD0.76
Volume Ratio
Nov 04, 2026
Next Earnings
17
+ve Days (30d)
13
-ve Days (30d)
JAZZ Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
JAZZ Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
JAZZ Options - Sort by Max open Interest (near term)
2nd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
JAZZ Daily Out of Money Options - Sort by Max open Interest (near term)
2nd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
JAZZ Daily In the Money Options - Sort by Max open Interest (near term)
2nd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
JAZZ Most Active Options by Volume(near term)
2nd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
JAZZ Technical Chart Pro Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
JAZZ Stock Summary
Last updated Oct 01, 2026
JAZZ is currently trading at $233.01, positioned above its 200-day moving average of $211.58, indicating a long-term uptrend. The stock has a 52-week range of $128.8 to $266.375.
Technical Analysis: The 50-day moving average stands at $247.6, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 38.64, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.095, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates JAZZ at 60.5/100 with a HOLD recommendation.
JAZZ (Jazz Pharmaceuticals, Inc.) Indicators
Last updated Oct 01, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 38.64 |
| CMF (20) | -0.095 |
| ROC (10) | -4.441 |
| ADX (14) | 22.594 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -3.724 |
| AROONOSC (14) | -78.571 |
| WILLAMS %R (14) | -80.016 |
| MFI (14) | 29.169 |
JAZZ Candlestick Patterns
No validated candlestick patterns fired for JAZZ in the last 10 sessions — that's normal. Only the ~15 patterns with a backtested edge (out of 60 textbook patterns) are tracked here.
Jazz Pharmaceuticals, Inc. is above the 200 Day SMA but below the 50 Day SMA — long-term uptrend intact but under near-term pressure (Mixed).
JAZZ Moving Averages Analysis
Jazz Pharmaceuticals, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Oct 01, 2026
JAZZ (Jazz Pharmaceuticals, Inc.) Simple Moving Averages
Moving Averages are last updated Oct 01, 2026
| Days | MA |
|---|---|
| 10 | 236.7 |
| 20 | 240.16 |
| 30 | 243.53 |
| 50 | 247.6 |
| 100 | 241.75 |
| 200 | 211.58 |
JAZZ Fundamental Analysis
| P/E (Forward) | 10.8932 |
| P/E (Trailing) | 15.8467 |
| Market Cap ($) | 15.0 billion |
| Earnings/Share ($) | 14.61 |
| Net Profit Margin (%) | 0.2045 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 24.9549 |
| EPS Estimate Next Year ($) | 25.7386 |
| WallStreet Target Price ($) | 292.81 |
| Most Recent Quarter |
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.